Ernexa Therapeutics (ERNAW) Gross Margin (2010 - 2024)

Ernexa Therapeutics (ERNAW) reported Gross Margin of 5.26% for Q4 2024, up 10526.0% on a YoY basis from N/an in Q1 2024, and down 95.31% quarter-over-quarter from 112.32% in Q3 2024.

Ernexa Therapeutics (ERNAW) Gross Margin (2010 - 2024) Analysis & Trends

Ernexa Therapeutics has reported Gross Margin for 13 years, with the latest figure at 5.26% in Q4 2024.

  • For the quarter ending Q4 2024, Gross Margin rose 10526.0% year-over-year to 5.26%; the trailing twelve-month figure through Dec 2024 stood at 81.0% (up 24900.0% YoY), and the FY2024 full-year result was 81.0%, up 24900.0% from the prior year.
  • Gross Margin for Q4 2024 stood at 5.26%, down from 112.32% in the prior quarter.
  • The five-year high for Gross Margin was 112.32% in Q3 2024, with the low at 135.29% in Q3 2023.
  • Historically, Gross Margin has averaged 27.04% across 3 years, with a median of 29.79% in 2024.
  • Annual changes were most pronounced in 2020 — Gross Margin slumped 897 bps — and 2024, when it surged 24761 bps.
  • Ernexa Therapeutics' Gross Margin stood at 60.32% in 2020, then sank by 266 bps to 100.0% in 2023, then jumped by 105 bps to 5.26% in 2024.
  • The last three Gross Margin figures came in at 5.26% (Q4 2024), 112.32% (Q3 2024), and 102.13% (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ernexa Therapeutics - - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 5.26%
Sep 30, 2024 112.32%
Jun 30, 2024 -102.13%
Mar 31, 2024 -29.79%
Dec 31, 2023 -100.00%
Sep 30, 2023 -135.29%
Mar 31, 2020 60.32%
Dec 31, 2019 43.15%
Sep 30, 2019 70.66%
Jun 30, 2019 67.15%
Mar 31, 2019 69.29%
Dec 31, 2018 65.35%
Sep 30, 2018 64.77%
Jun 30, 2018 65.72%
Mar 31, 2018 65.86%
Dec 31, 2017 79.59%
Sep 30, 2017 70.39%
Jun 30, 2017 70.61%
Mar 31, 2017 64.77%
Dec 31, 2016 149.76%